Top

Sleep and Breathing

Published in:

01-09-2020 | Sleep Apnea | Sleep Breathing Physiology and Disorders • Original Article

Association of serum adiponectin level with cystatin C in male patients with obstructive sleep apnea syndrome

Authors: Dong-Dong Chen, Jie-Feng Huang, Song-Ping Huang, Xiao-Fang Chen

Published in: Sleep and Breathing | Issue 3/2020

Abstract

Purpose

Obstructive sleep apnea syndrome (OSAS) was suggested to exert an effect on renal function. However, the specific mechanism was still unknown. We try to find the association among OSAS, adiponectin, and cystatin C and the effect of adiponectin on renal function in OSAS patients.

Methods

Seventeen healthy men and seventy-three men which only had OSAS were included in the end. Apnea-hypopnea index (AHI), oxygen desaturation index (ODI), the percentage of total sleep time spent with SpO₂ < 90% (T90%), lowest O₂ saturation (LaSO₂), Epworth Sleepiness Scale (ESS) score, serum adiponectin, and high-sensitive C-reactive protein (hsCRP) were detected in all subjects, and renal function was evaluated with creatinine, cystatin C, and estimated glomerular filtration rate (eGFR).

Results

Demographic data, creatinine, and eGFR did not differ among the studied groups. Decreased serum adiponectin levels were associated with severe OSAS. OSAS patients had a higher hsCRP and cystatin C than those without OSAS. Serum adiponectin levels had a negative association with cystatin C. After adjusted for confounders, adiponectin, hsCRP, and ODI had a significant prediction on the cystatin C (β = − 0.218, p = 0.011; β = 0.226, p = 0.037; and β = 0.231, p = 0.029).

Conclusions

Decreased serum adiponectin was associated with increased cystatin C in male OSAS patients. These results suggest that serum adiponectin might be a regulatory factor for renal function in OSAS.

Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3(4):310–318. https://doi.org/10.1016/S2213-2600(15)00043-0CrossRefPubMedPubMedCentral

Levy P, Tamisier R, Minville C, Launois S, Pepin JL (2011) Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev 20(121):134–146. https://doi.org/10.1183/09059180.00003111CrossRefPubMed

Adams RJ, Appleton SL, Vakulin A, Hanly PJ, McDonald SP, Martin SA, Lang CJ, Taylor AW, McEvoy RD, Antic NA, Catcheside PG, Vincent AD, Wittert GA (2017) Chronic kidney disease and sleep apnea association of kidney disease with obstructive sleep apnea in a population study of men. Sleep 40:1. https://doi.org/10.1093/sleep/zsw015CrossRef

Uyar M, Davutoglu V, Gundogdu N, Kosovali D, Sari I (2016) Renal functions in obstructive sleep apnea patients. Sleep Breath 20(1):191–195. https://doi.org/10.1007/s11325-015-1204-0CrossRefPubMed

Kim HY, Bae EH, Ma SK, Chae DW, Choi KH, Kim YS, Hwang YH, Ahn C, Kim SW (2016) Association of serum adiponectin level with albuminuria in chronic kidney disease patients. Clin Exp Nephrol 20(3):443–449. https://doi.org/10.1007/s10157-015-1173-4CrossRefPubMed

Sethna CB, Boone V, Kwok J, Jun D, Trachtman H (2015) Adiponectin in children and young adults with focal segmental glomerulosclerosis. Pediatr Nephrol 30(11):1977–1985. https://doi.org/10.1007/s00467-015-3146-yCrossRefPubMed

Masserini B, Morpurgo PS, Donadio F, Baldessari C, Bossi R, Beck-Peccoz P, Orsi E (2006) Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Investig 29(8):700–705. https://doi.org/10.1007/BF03344179CrossRef

Kim J, Lee CH, Park CS, Kim BG, Kim SW, Cho JH (2010) Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg 136(9):896–899. https://doi.org/10.1001/archoto.2010.142CrossRefPubMed

Zhang XL, Yin KS, Wang H, Su S (2006) Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 73(1):73–77. https://doi.org/10.1159/000088690CrossRefPubMed

10.

Zhang XB, Lin QC, Deng CS, Chen GP, Cai ZM, Chen H (2013) Elevated serum cystatin C in severe OSA younger men without complications. Sleep Breath 17(1):235–241. https://doi.org/10.1007/s11325-012-0678-2CrossRefPubMed

11.

Schulz H (2007) Phasic or transient? Comment on the terminology of the AASM manual for the scoring of sleep and associated events. J Clin Sleep Med 3(7):752CrossRef

12.

Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T, Racineux JL (2003) Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22(1):156–160. https://doi.org/10.1183/09031936.03.00089902CrossRefPubMed

13.

Voulgaris A, Archontogeorgis K, Nena E, Tsigalou C, Xanthoudaki M, Kouratzi M, Tripsianis G, Froudarakis M, Steiropoulos P (2018) Serum levels of NGAL and cystatin C as markers of early kidney dysfunction in patients with obstructive sleep apnea syndrome. Sleep Breath 23:161–169. https://doi.org/10.1007/s11325-018-1677-8CrossRefPubMed

14.

Archontogeorgis K, Nena E, Tsigalou C, Voulgaris A, Xanthoudaki M, Froudarakis M, Steiropoulos P (2016) Cystatin C levels in middle-aged patients with obstructive sleep apnea syndrome. Pulm Med 2016:8081723. https://doi.org/10.1155/2016/8081723CrossRefPubMedPubMedCentral

15.

Chen Y, Li Y, Jiang Q, Xu X, Zhang X, Simayi Z, Ye H (2015) Analysis of early kidney injury-related factors in patients with hypertension and obstructive sleep apnea hypopnea syndrome (OSAHS). Arch Iran Med 18(12):827–833PubMed

16.

Koga S, Ikeda S, Yasunaga T, Nakata T, Maemura K (2013) Effects of nasal continuous positive airway pressure on the glomerular filtration rate in patients with obstructive sleep apnea syndrome. Intern Med 52(3):345–349. https://doi.org/10.2169/internalmedicine.52.8468CrossRefPubMed

17.

Maski MR, Thomas RJ, Karumanchi SA, Parikh SM (2016) Urinary neutrophil gelatinase-associated lipocalin (NGAL) in patients with obstructive sleep apnea. PLoS One 11(5):e0154503. https://doi.org/10.1371/journal.pone.0154503CrossRefPubMedPubMedCentral

18.

Turek NF, Ricardo AC, Lash JP (2012) Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence. Am J Kidney Dis 60(5):823–833. https://doi.org/10.1053/j.ajkd.2012.04.027CrossRefPubMedPubMedCentral

19.

Kinebuchi S, Kazama JJ, Satoh M, Sakai K, Nakayama H, Yoshizawa H, Narita I, Suzuki E, Gejyo F (2004) Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 107(3):317–322. https://doi.org/10.1042/CS20040074CrossRef

20.

Hanly PJ, Ahmed SB (2014) Sleep apnea and the kidney: is sleep apnea a risk factor for chronic kidney disease? Chest 146(4):1114–1122. https://doi.org/10.1378/chest.14-0596CrossRefPubMed

21.

Sayk F, Teckentrup C, Becker C, Heutling D, Wellhoner P, Lehnert H, Dodt C (2010) Effects of selective slow-wave sleep deprivation on nocturnal blood pressure dipping and daytime blood pressure regulation. Am J Phys Regul Integr Comp Phys 298(1):R191–R197. https://doi.org/10.1152/ajpregu.00368.2009CrossRef

22.

Jin ZN, Wei YX (2016) Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. J Geriatr Cardiol 13(4):333–343. https://doi.org/10.11909/j.issn.1671-5411.2016.03.020CrossRefPubMedPubMedCentral

23.

Christou GA, Kiortsis DN (2014) The role of adiponectin in renal physiology and development of albuminuria. J Endocrinol 221(2):R49–R61. https://doi.org/10.1530/JOE-13-0578CrossRefPubMed

24.

Dubern B, Lafarge JC, Fellahi S, Naour N, Copin N, Bastard JP, Simon C, Clement K, Bonnet D, Tounian P, Guerre-Millo M (2012) Relevance of increased serum cystatin C to vascular alterations in obese children. Pediatr Obes 7(5):374–381. https://doi.org/10.1111/j.2047-6310.2012.00053.xCrossRefPubMed

25.

Moller KF, Dieterman C, Herich L, Klaassen IA, Kemper MJ, Muller-Wiefel DE (2012) High serum adiponectin concentration in children with chronic kidney disease. Pediatr Nephrol 27(2):243–249. https://doi.org/10.1007/s00467-011-1971-1CrossRefPubMed

26.

Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118(5):1645–1656. https://doi.org/10.1172/JCI32691CrossRefPubMedPubMedCentral

27.

Yu Y, Bao BJ, Fan YP, Shi L, Li SQ (2014) Changes of adiponectin and its receptors in rats following chronic renal failure. Ren Fail 36(1):92–97. https://doi.org/10.3109/0886022X.2013.830975CrossRefPubMed

28.

Lim CC, Teo BW, Tai ES, Lim SC, Chan CM, Sethi S, Wong TY, Sabanayagam C (2015) Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. PLoS One 10(3):e0122009. https://doi.org/10.1371/journal.pone.0122009CrossRefPubMedPubMedCentral

29.

Vatansever E, Surmen-Gur E, Ursavas A, Karadag M (2011) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15(3):275–282. https://doi.org/10.1007/s11325-010-0378-8CrossRefPubMed

30.

Walters SJ (2009) Consultants’ forum: should post hoc sample size calculations be done? Pharm Stat 8(2):163–169. https://doi.org/10.1002/pst.334CrossRefPubMed

Title: Association of serum adiponectin level with cystatin C in male patients with obstructive sleep apnea syndrome
Authors: Dong-Dong Chen
Jie-Feng Huang
Song-Ping Huang
Xiao-Fang Chen
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keyword: Sleep Apnea
Published in: Sleep and Breathing / Issue 3/2020
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-019-01927-y

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Association of serum adiponectin level with cystatin C in male patients with obstructive sleep apnea syndrome

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2020

Visfatin as a predictor of obstructive sleep apnea in atrial fibrillation patients

A stepwise titration protocol for oral appliance therapy in positional obstructive sleep apnea patients: proof of concept

Letter to the editor: snoring and incident cardiovascular disease in the Jackson heart study

The impact of oral appliance therapy with moderate mandibular advancement on obstructive sleep apnea and upper airway volume

The impact of depression, self-esteem, and body image on sleep quality in patients with PCOS: a cross-sectional study

Obstructive sleep apnea syndrome (OSAS) and swallowing function—a systematic review

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page